These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5162252)

  • 21. Glucose tolerance, plasma insulin and lipids in postmenopausal women during sequential oestrogen-progestin treatment.
    Pyörälä K; Pyörälä T; Lampinen V; Taskinen MR
    Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:28. PubMed ID: 5287100
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects.
    Sabuncu T; Ucar E; Birden F; Yasar O
    Diabetes Nutr Metab; 2004 Apr; 17(2):103-7. PubMed ID: 15244102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbohydrate-induced hypertriglyceridemia: inhibition by phenformin.
    Owen WC; Kreisberg RA; Siegal AM
    Diabetes; 1971 Nov; 20(11):739-44. PubMed ID: 5115588
    [No Abstract]   [Full Text] [Related]  

  • 24. The incidence of plasma insulin, blood sugar and serum lipid abnormalities in patients with atherosclerotic disease.
    Sloan JM; Mackay JS; Sheridan B
    Diabetologia; 1971 Dec; 7(6):431-3. PubMed ID: 5144549
    [No Abstract]   [Full Text] [Related]  

  • 25. Interrelationships of hyperinsulinism and hypertriglyceridemia in young patients with coronary heart disease.
    Tzagournis M; Chiles R; Ryan JM; Skillman TG
    Circulation; 1968 Dec; 38(6):1156-63. PubMed ID: 5721965
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of lipotropin on blood lipids in patients with myocardial infarction.
    Kedra M; Kolber-Postepska B; Miturzyńska-Stryjecka H
    Pol Med J; 1971; 10(3):583-9. PubMed ID: 5124127
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of FK506 versus cyclosporine on glucose and lipid metabolism--a randomized trial.
    Steinmüller TM; Gräf KJ; Schleicher J; Leder K; Bechstein WO; Mueller AR; Dette K; Schulz E; Neuhaus P
    Transplantation; 1994 Sep; 58(6):669-74. PubMed ID: 7524203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose tolerance, serum insulin, and serum lipids in athletes.
    Cüppers HJ; Erdmann D; Schubert H; Berchtold P; Berger M
    Curr Probl Clin Biochem; 1982; 11():155-65. PubMed ID: 7044692
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of hypoglycemic therapy on blood lipids and body weight in diabetes mellitus.
    Mirsky S
    Ann N Y Acad Sci; 1968 Mar; 148(3):937-44. PubMed ID: 4872314
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased levels of plasma insulin and eleven hydroxycorticosteroid induced by sucrose, and their reduction by phenformin.
    Yudkin J; Szanto S
    Horm Metab Res; 1972 Nov; 4(6):417-20. PubMed ID: 4570364
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of ageing on prednisone-glucose tolerance and serum lipids.
    Jakobson T; Kahanpää A
    Ann Med Intern Fenn; 1968; 57(1):9-14. PubMed ID: 5726765
    [No Abstract]   [Full Text] [Related]  

  • 32. Circulating lipids and cardiovascular risk in newly diagnosed non-insulin-dependent diabetic subjects in India.
    Shelgikar KM; Naik SS; Khopkar M; Bhat DS; Raut KN; Joglekar CV; Gerard ME; Yajnik CS
    Diabet Med; 1997 Sep; 14(9):757-61. PubMed ID: 9300225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased plasma levels of tissue factor pathway inhibitor (TFPI) after n-3 polyunsaturated fatty acids supplementation in patients with chronic atherosclerotic disease.
    Berrettini M; Parise P; Ricotta S; Iorio A; Peirone C; Nenci GG
    Thromb Haemost; 1996 Mar; 75(3):395-400. PubMed ID: 8701396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma glucose, insulin and lipids during growth of genetically lean and obese swine.
    Mersmann HJ; Pond WG; Yen JT
    Growth; 1982; 46(3):189-98. PubMed ID: 6757063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Arteriosclerosis and serum lipids].
    Wada M
    Rinsho Byori; 1969 Aug; 17(8):604-9. PubMed ID: 5391165
    [No Abstract]   [Full Text] [Related]  

  • 36. Protease therapy and changes to insulin and glucose.
    TreatmentUpdate; 1999 Jun; 11(4):5-6. PubMed ID: 11366792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Serum-lipid reducing principles--possibilities for treatment. 3. Physical training and lipid reduction].
    Björntorp P
    Lakartidningen; 1970 Dec; 67():Suppl IV:46+. PubMed ID: 5512785
    [No Abstract]   [Full Text] [Related]  

  • 38. [Collagen metabolism indices, and plasma concentrations of lipids, cyclic 3',5'-AMP, and certain hormones in 40-59-year-old men].
    Bazanov EA; Gerasimova EN; Ozerova IN; Bezhanian MV; Suchkova SN
    Vopr Med Khim; 1980; 26(4):464-70. PubMed ID: 6256961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality from coronary heart disease during phenformin therapy.
    Tzagournis M; Reynertson R
    Ann Intern Med; 1972 Apr; 76(4):587-92. PubMed ID: 4640317
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term effect of pindolol on plasma lipids, apoproteins A, blood glucose, and serum insulin levels.
    Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):269-72. PubMed ID: 6430812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.